Allgens Medical Technology CO., LTD. (688613.SS)
CNY 18.52
(0.76%)
CNY 18.52
(0.76%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 226.47 Million CNY | -7.68% |
| 2022 | 245.3 Million CNY | 3.92% |
| 2021 | 236.06 Million CNY | 28.46% |
| 2020 | 183.76 Million CNY | 9.0% |
| 2019 | 168.59 Million CNY | 36.3% |
| 2018 | 123.68 Million CNY | 35.36% |
| 2017 | 91.37 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 51.89 Million CNY | 11.6% |
| 2024 Q3 | 47.3 Million CNY | -7.37% |
| 2024 Q1 | 46.5 Million CNY | 8.44% |
| 2023 Q4 | 42.87 Million CNY | -34.63% |
| 2023 Q2 | 70.19 Million CNY | 46.83% |
| 2023 Q1 | 47.8 Million CNY | -31.05% |
| 2023 FY | 226.47 Million CNY | -7.68% |
| 2023 Q3 | 65.59 Million CNY | -6.56% |
| 2022 Q1 | 45.89 Million CNY | -43.56% |
| 2022 Q2 | 58.44 Million CNY | 27.36% |
| 2022 FY | 245.3 Million CNY | 3.92% |
| 2022 Q4 | 69.33 Million CNY | -3.2% |
| 2022 Q3 | 71.62 Million CNY | 22.56% |
| 2021 FY | 236.06 Million CNY | 28.46% |
| 2021 Q2 | 54.54 Million CNY | 48.69% |
| 2021 Q1 | 36.68 Million CNY | -54.99% |
| 2021 Q4 | 81.3 Million CNY | 28.01% |
| 2021 Q3 | 63.51 Million CNY | 16.45% |
| 2020 FY | 183.76 Million CNY | 9.0% |
| 2020 Q1 | 14.52 Million CNY | -74.77% |
| 2020 Q2 | 27.1 Million CNY | 86.62% |
| 2020 Q3 | 60.61 Million CNY | 123.59% |
| 2020 Q4 | 81.51 Million CNY | 34.49% |
| 2019 FY | 168.59 Million CNY | 36.3% |
| 2019 Q4 | 57.56 Million CNY | 0.0% |
| 2018 FY | 123.68 Million CNY | 35.36% |
| 2017 FY | 91.37 Million CNY | 0.0% |